China Healthwise flags sharp narrowing of annual loss on valuation gains

China Healthwise Holdings ( (HK:0348) ) has provided an update.

China Healthwise Holdings Limited has warned investors that it expects to narrow its loss attributable to shareholders for the year ended 31 December 2025 to between HK$1.8 million and HK$3.4 million, a sharp improvement of about 92% to 96% from the HK$40 million loss recorded a year earlier. The turnaround is mainly driven by an estimated HK$25 million unrealised fair value gain on financial assets and about HK$4 million in reversals of earlier credit impairments, though the figures are based on unaudited management accounts and remain subject to adjustment when full annual results are approved on 27 March 2026.

The company’s improved earnings profile, if confirmed, would signal a marked easing of financial pressure following last year’s heavy loss, with valuation gains and better credit performance offsetting previous write-downs. However, management has cautioned shareholders and potential investors that the numbers may change once the audit is completed and urged them to exercise care when dealing in the company’s shares ahead of the final results announcement.

The most recent analyst rating on (HK:0348) stock is a Hold with a HK$0.14 price target. To see the full list of analyst forecasts on China Healthwise Holdings stock, see the HK:0348 Stock Forecast page.

More about China Healthwise Holdings

China Healthwise Holdings Limited, incorporated in the Cayman Islands and listed in Hong Kong, operates through a group structure providing products and services that generate both operating income and financial asset exposures. The company’s results are influenced by fair value movements in financial assets and the credit performance of its loan, trade and other receivables portfolios.

Average Trading Volume: 234,969

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$72.43M

For detailed information about 0348 stock, go to TipRanks’ Stock Analysis page.